The gut microbiota contributes to the development of normal immunity but, when dysregulated, can promote autoimmunity through various non-antigen-specific effects on pathogenic and regulatory lymphocytes. Here, we show that an integrase expressed by several species of the gut microbial genus Bacteroides encodes a low-avidity mimotope of the pancreatic b cell autoantigen islet-specific glucose-6-phosphatase-catalytic-subunit-related protein ). Studies in germ-free mice monocolonized with integrase-competent, integrase-deficient, and integrase-transgenic Bacteroides demonstrate that the microbial epitope promotes the recruitment of diabetogenic CD8+ T cells to the gut. There, these effectors suppress colitis by targeting microbial antigen-loaded, antigen-presenting cells in an integrin b7-, perforin-, and major histocompatibility complex class I-dependent manner. Like their murine counterparts, human peripheral blood T cells also recognize Bacteroides integrase. These data suggest that gut microbial antigen-specific cytotoxic T cells may have therapeutic value in inflammatory bowel disease and unearth molecular mimicry as a novel mechanism by which the gut microbiota can regulate normal immune homeostasis.
INTRODUCTION
Type 1 diabetes (T1D) in nonobese diabetic (NOD) mice is the result of a CD4+ and CD8+ T-cell-dependent autoimmune process against pancreatic b cells. A large fraction of the NOD islet-associated CD8+ T cells recognize a dominant peptide/K d complex (Anderson et al., 1999) displaying amino acid residues 206-214 of islet-specific glucose-6-phosphatase catalytic subunit-related protein ) (Lieberman et al., 2003) . This T cell specificity circulates at unusually high frequencies in prediabetic NOD mice (Amrani et al., 2000; Trudeau et al., 2003) . An unusual feature of the IGRP 206-214 -reactive CD8+ T cell subset is that most of its clonotypes use a quasi-invariant T cell receptor alpha (TCRa) rearrangement that employs Va17 and Ja42 elements joined by three germline-encoded residues (Anderson et al., 1999; Han et al., 2005b) . Differences in avidity among clonotypes are largely determined by differential Va17 usage (Anderson et al., 1999; Han et al., 2005b) and account for the increased proclivity to tolerance (central and peripheral) and superior competitive fitness (in the islet lesion) of high-versus lowavidity clonotypes (Amrani et al., 2000; Han et al., 2005b) . Islet inflammation fuels the local expansion of the highest avidity T cell pools (Va17.5+ and 17.4+) (Han et al., 2005b) and the development of memory-like autoregulatory CD8+ T cells from the low-avidity pool (Va17.6+) (Shameli et al., 2011 (Shameli et al., , 2013 Tsai et al., 2010) . Whereas the high-avidity clones promote disease by killing b cells, the memory-like autoregulatory CD8+ T cells suppress disease by targeting autoantigen-loaded antigen-presenting cells (APCs) The high peripheral precursor frequency and dominant expression of a quasi-invariant TCRa raised the possibility that this T cell specificity might have been evolutionarily maintained because it was beneficial to the host. Studies on the developmental biology of high-versus low-avidity IGRP 206-214 -reactive clonotypes in TCR-transgenic (TG), IGRP 206-214 -deficient NOD mice revealed that dynamic changes in the size and avidity of the peripheral IGRP 206-214 -reactive CD8+ T cell pool could not be accounted for by recognition of IGRP [206] [207] [208] [209] [210] [211] [212] [213] [214] alone (Wang et al., 2012; Wang et al., 2010) . This prompted us to entertain the possibility that this T cell subset might also recognize another epitope(s). Here, we discover a gut microbial antigen that affords diabetogenic IGRP 206-214 -reactive CD8+ T cells anti-colitogenic properties, exposing a novel mechanism by which peripheral T cells can inhibit overreactive immune responses against gut microbial antigens and thus regulate homeostasis of the gutassociated lymphoid system.
RESULTS

Identification of a Gut Microbial Antigen Mimic of Mouse and Human IGRP 206-214
We searched the NCBI microbial protein database for amino acid sequences homologous to murine IGRP [206] [207] [208] [209] [210] [211] [212] [213] [214] . Homologous sequences were ranked according to their predicted H-2K d -binding avidity (Table S1 ). The strongest predicted binder ) differs from IGRP [206] [207] [208] [209] [210] [211] [212] [213] [214] by two conserved amino acids (Table S1 ) and is found in proteins affiliated with a transposable integrase/tyrosine recombinase protein family (hereinafter referred to as ''integrase'') encoded by Bacteroides species present in the gut microbiotas of rodents and humans. The BacIYL [36] [37] [38] [39] [40] [41] [42] [43] [44] 1C) . Surprisingly, and unlike IGRP 2016-214 , BacIYL [36] [37] [38] [39] [40] [41] [42] [43] [44] had agonistic activity only on 17.4 (and not 17.6) CD8+ T cells and only at high concentrations (10-50 mg/mL) ( Figures 1D, S1A , and S1B). Whereas the bacterial toll-like receptor (TLR) ligand lipopolysaccharide (LPS) enhanced responsiveness of 17.4 CD8+ T cells to BacIYL [36] [37] [38] [39] [40] [41] [42] [43] [44] , it had no effect on the inability of 17.6-CD8+ T cells to respond . These effects were not seen when using non-TCR-TG T cells (Figures 1D and S1A) . Thus, whereas both 17.4-and 17.6-CD8+ T cells bind BacIYL 36-44 /K d tetramers, only the former can mount in vitro responses to peptide-pulsed APCs.
Flow cytometric analyses of CD8+ T cells from the spleen, lymph nodes and gut-associated lymphoid tissues (GALTs) of NOD mice using allophycocyanin (AP)-labeled NRP-V7(IGRP [206] [207] [208] [209] [210] [211] [212] [213] [214] (Figures 1E and S1D) . Such cells were also found at similarly high frequencies in two of five other H-2K d -expressing mouse strains (BALB/cJ and NZBWF1/J) (Figures 1E and S1D) .
The low functional avidity of IGRP 2016-214 -reactive CD8+ T cells for BacIYL [36] [37] [38] [39] [40] [41] [42] [43] [44] prompted us to consider four additional homologous peptides predicted to bind to H-2K d with lower affinity than BacIYL 36-44 (peptides also reported by Tai et al. (2016) : W15944, W15945, W15946 and W15948; Table S1 ). Two of these (W15946 and W15948) stabilized H-2K d expression in RMA-S-H-2K d cells similar to BacIYL [36] [37] [38] [39] [40] [41] [42] [43] [44] , but the other two (W15945 and W15944) did so with much lower efficiency (Figure S1E) . Unlike BacIYL [36] [37] [38] [39] [40] [41] [42] [43] [44] , which only triggers IFNg secretion by 17.4-CD8+ T cells, all four W peptides triggered the secretion of IFNg by both 17.4-and 17.6-CD8+ T cells ( Figure S1F ), and the corresponding W peptide-K d tetramers bound to both T cell types equally well ( Figure S1G ).
However, unlike the case for the Bacteroides integrase gene, none of the genes encoding these four peptides (found in Leptotrichia goodfellowii, Flavobacteriia bacterium, Bacillus cereus, and Enterobacter mori, respectively) could be detected in stool DNA from our specific pathogen-free (SPF) mice, as determined by PCR ( Figure S2A ), 16S rDNA ( Figure S2B ), and metagenome sequence analyses ( Figures S2C-S2E ). The stool metagenomes of 20 of 24 mice contained genes encoding IGRP 206-214 mimics ( Figures S2C-S2E ). All these genes encoded BacIYL 36-44 and were from Bacteroides vulgatus, which on average comprised 9% of stool bacteria (0.3%-41%) . Thus, the Bacteroides vulgatus integrase is the primary source of microbial genes encoding IGRP [206] [207] [208] [209] [210] [211] [212] [213] [214] mimics in the stool metagenomes of the mouse strains studied herein.
To investigate if dendritic cells (DCs) could process the integrase for cross-presentation of BacIYL 36-44 , we expressed a 100 amino acid fragment of integrase harboring the BacIYL [36] [37] [38] [39] [40] [41] [42] [43] [44] epitope in E. coli (BacInt100aa). BacInt100aa-fed, but not ovalbumin (OVA)-fed, DCs triggered the secretion of IFNg by 17.4-CD8+ T cells in the presence of LPS ( Figure 1F ), indicating that the BacIYL 36-44 epitope is a bona fide, low-avidity antigenic target of high-avidity IGRP 206-214 -reactive CD8+ T cells.
We next asked if human peripheral blood mononuclear cells (PBMCs) might also harbor T cells recognizing the integrase. PBMCs from 5 out of 5 healthy individuals proliferated to BacInt100aa, and these responses were almost completely abrogated by the addition of anti-MHC class I and, to a lower extent, class II antibodies ( Figure 1G ). Experiments using PBMCs from 10 patients with T1D or Crohn's disease (CD) suggested that BacInt100aa-reactive CD8+ T cells are also present in the former and, to a significantly lower extent, the latter ( Figure S3A ). Since the human and murine IGRP sequences around residues 206-214 are homologous, we searched for amino acid sequences at around hIGRP [206] [207] [208] [209] [210] [211] [212] [213] [214] and BacInt [36] [37] [38] [39] [40] [41] [42] [43] [44] that are capable of binding to a prevalent HLA class I allelic type (HLA-A*02:01). Two epitopes fitting these criteria, hIGRP [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] and BacKIY [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] , were chosen for further experimentation. We produced PE-and APlabeled HLA-A*02:01 pentamers displaying either sequence and enumerated the presence of CD8+ T cells capable of binding (mean ± SEM) correspond to 6-to 8-week-old mice (C57BL6/J, n = 3; NOD-Ltj, n = 5; Balbc/J, n = 7; C57BLKS/J, n = 3; NZBWF1/J, n = 5; DBA/2J, n = 3; and 6D2F1/J, n = 3). Figure S3B ). Metagenomic sequencing of stool DNA from healthy controls and T1D and CD patients confirmed the presence of integrasecarrying Bacteroides (B. dorei, B. vulgatus, and B. spp) Figure S4 ). On average, Bacteroides species comprised 27% of stool bacteria (0.3%-66%). Analyses of publicly available shotgun metagenomic datasets from prediabetic and diabetic T1D patients (Kostic et al., 2015) , CD patients (Lewis et al., 2015) , and controls (Kostic et al., 2015; Lewis et al., 2015; Wu et al., 2011) yielded similar observations ( Figure S5 ). Thus, there is a high prevalence of integrase-expressing Bacteroides in the human gut microbiome, and the human peripheral CD8+ T cell repertoire, like its murine counterpart, harbors Bacteroides integrase-reactive clonotypes.
IGRP 206-214 -Reactive CD8+ T Cells Home to and Proliferate in the GALT Most of the thymic, splenic, and mesenteric lymph node (MLN) CD8+CD4À T cells of IGRP-deficient 17.4-and 17.6-NOD mice express the gut-homing integrins b7 and aE (CD103), but not integrin-a4 or a4b7 integrin (lymphocyte Peyer's patch adhesion molecule [LPAM]-1) ( Figure 1H ). In vivo BrdU incorporation experiments in IGRP-deficient NOD hosts transfused with naive (CD122-) IGRP 206-214 -specific TCR-TG or control LCMV-Gp33-specific P14-TCR-TG CD8+ T cells (integrin-b7+ and integrinaE+ but not known to cross-react with gut microbial antigens) indicated that both 17.4-and 17.6-, but not P14-CD8+, T cells proliferate in the lamina propria (LP) and intestinal epithelium (IE) ( Figure 1I ). Thus, the naive CD8+ T cells of 17.4-and, to a lesser extent, 17.6-NOD mice home to and proliferate in the GALT.
Recruitment of IGRP 206-214 -Reactive CD8+ T Cells to the GALT Affords Resistance to Colitis Since inflammatory bowel disease (IBD) is thought to result from innate and adaptive T cell immune responses (APC-dependent) to gut microbes (Strober, 2013), we reasoned that this naturally occurring CD8+ T cell cross-reactivity may have arisen in response to evolutionary pressure to maintain gut microbe homeostasis.
To investigate whether a colitis-triggering insult promotes the migration of IGRP 206-214 /BacIYL 36-44 -reactive CD8+ T cells to the GALT, we exposed NOD mice to chronic dextran sulfate sodium (DSS) treatment and measured the frequencies of IGRP 206-214 /BacIYL 36-44 -reactive CD8+ T cells in peripheral lymphoid organs and GALT. As shown in Figure 2A , there was a significant decrease in the percentages of tetramer+ cells in spleen and peripheral lymph nodes and a reciprocal enrichment for these cells in the GALT, suggesting that DSS-induced breakdown of the gut barrier promotes the recruitment of BacIYL 36-44 -reactive CD8+ T cells.
We next probed whether BacIYL 36-44 -driven interactions between cognate CD8+ T cells and gut-associated APCs might contribute to the progression of or protection against colitis. IGRP-deficient 17.4-and 17.6-NOD mice were exposed to 2% DSS in the drinking water for one week to compromise gut epithelial integrity and increase bacterial dissemination without inducing overt disease. After an additional week on normal water, these mice were exposed to chronic DSS treatment (as above). As shown in Figures 2B-2K , IGRP-deficient 17.4-NOD mice exhibited resistance to colitis and no mortality as compared to (1) IGRP-deficient 17.6-NOD mice, whose CD8+ T cells recognize ( Figure 1B ) but fail to respond to BacIYL 36-44 in vitro (Figures 1D and S1A-S1C), or (2) non-TG NOD mice, which harbor significantly lower numbers of IGRP 206-214 -reactive CD8+ T cells. These data were further supported by studies of 17.4-NOD mice lacking integrin-b7, in which T cells cannot migrate to the GALT ( Figures 2L-2O) , and of IGRP-deficient NOD mice, which harbor increased numbers of high-avidity IGRP 206-214 -reactive (BacIYL 36-44 cross-reactive) CD8+ T cells (Wang et al., 2012) (Figure 2P ). Thus, recruitment of high-avidity IGRP 206-214 -reactive CD8+ T cells to the gut affords resistance to colitis.
The Anti-colitogenic Activity of IGRP 206-214 -Reactive CD8+ T cells Is Driven by an MHC Class I-Restricted Cytotoxic Effect against DCs Whereas low-avidity IGRP 206-214 -reactive CD8+ T cells (i.e., 17.6-CD8+ T cells) suppress diabetes development, their higher-avidity counterparts (i.e., 17.4-CD8+ T cells) promote it (Amrani et al., 2000; Han et al., 2005b) . This occurs because 17.6-CD8+ T cells, unlike their 17.4-CD8+ counterparts, differentiate into a memory-like FoxP3
hi GrB + CD8+ T cell subset that specifically kills autoantigen-loaded DCs in the pancreatic lymph nodes (PLNs) in a perforin-dependent manner while sparing pancreatic b-cells, which express significantly lower densities of cognate pMHC class I complexes (Tsai et al., 2010; Shameli et al., 2011) . These observations, coupled with the ability of 17.4-CD8+ T cells to recognize BacIYL 36-44 -loaded APCs with low avidity ( Figures 1D, 1F , and S1A-S1C), raised the possibility that the latter might suppress colitis by killing integrase-loaded DCs in the GALT. Exploratory studies of IGRP-deficient NOD mice carrying CD11c or CD11b promoter-driven diphtheria toxin receptor (DTR) transgenes indicated that transient deletion of CD11c+ or CD11b+ cells with DT afforded resistance to DSS-induced colitis ( Figures S6A-S6D ). Furthermore, whereas 17.4 cytotoxic T lymphocytes (CTL; differentiated in vitro by stimulation with IGRP 206-214 peptide-pulsed APCs) displayed cytolytic activity against BacIYL 36-44 -pulsed RMA-S-K d cells over a broad range of concentrations (2-250 mg/mL), 17.6-CTL only displayed marginal cytotoxic activity against cells pulsed with 250 mg/mL of peptide ( Figure 3A ). Figure 3C ). Together, the outcome of these experiments supported the hypothesis that resistance to colitis afforded by 17.4-CD8+ (mice that lost > 20% of body weight before termination of the experiment) or at the end of follow-up. Data correspond to 6-to 8-week-old male mice (n = 6 and 5 mice on DSS, respectively; and n = 4 mice on water). p values were calculated by ANOVA. Data are from three experiments. (C-E) Disease activity scores (C) , survival curves (D) , and colon lengths (E) corresponding to the mice in (B) . p values were calculated by Mann-Whitney U (C and E) or c2 ( -/-mice in response to two 3-week cycles of 3.5% DSS treatment (1 week on DSS, 2 weeks on water). Data correspond to 6-to 8-week-old male mice subjected to the prime-boost model of colitis (n = 3 and 4, respectively). p values were calculated using ANOVA.
T cells might be mediated by a cytotoxic CD8+ T cell response against BacIYL 36-44 -loaded APCs.
To further investigate the role of DC killing, we transferred 17.4-CTL (differentiated by stimulation with IGRP 206-214 ) to IGRP-deficient NOD hosts treated with 4% DSS. 17.4-CTLtransfused hosts had lower disease activity scores than 17.6-CTL-transfused or non-transfused mice ( Figure 3D ). We obtained similar results when we used 17.6-NOD hosts ( Figures  3E-3I ) or when the 17.4-CTLs were differentiated by stimulation with BacIYL [36] [37] [38] [39] [40] [41] [42] [43] [44] (Figures 3J-3M ).
The anti-colitogenic effect of 17.4-CTL transfer required a cytolytic effect because 17.6-NOD.Tcra -/-.Igrp 206-214 -/-hosts receiving perforin-deficient 17.4-CTL were no longer protected from weight loss, severe colitis, colon shortening, and death as compared to non-transfused hosts or hosts transfused with perforin-competent CTL ( Figures 4A-4E ). Furthermore, experiments using conditional ablation of b2-microglobulin in CD11c+ and, to a lesser degree, CD11b+ cells ( Figure 4F ) demonstrated that these anti-colitogenic effects also required a cognate interaction between DCs and gut-antigen-specific CD8+ T cells ( Figures  4G-4J ). intra-rectal administration of dinitrobenzene sulfonic acid (DNBS) (Figures 5A-5C), and expression of the TG 17.4-TCR, but not its 17.6-TCR counterpart, protected IGRP/Tcra-deficient NOD mice from CD4+CD25-T cell-induced colitis ( Figure 5D -5H). Together, these data support the hypothesis that a CTL response against BacIYL 36-44 -loaded APCs affords resistance to colitis, presumably by short-circuiting the activation of colitogenic, gut microbial antigen-specific CD4+ T cells.
Anti-colitogenic Activity in Other Models of Colitis
The Anti-colitogenic Activity of IGRP 206-214 -Reactive CTL Is Bacteroides Integrase-Dependent To unequivocally confirm a role for the Bacteroides integrase antigen in the anti-colitogenic activity of IGRP 206-214 -reactive CTL, we monocolonized germ-free (GF) BALB/c and IGRP-deficient 17.6-NOD mice with Bacteroides spp. carrying or lacking the BacIYL-encoding integrase and assessed the ability of 17.4-CTL to protect the mice from DNBS-induced colitis. Archived DNA sequencing data indicated that the following strains carried one or more copies of the integrase gene:
B. vulgatus; B. sp. 4_3_47FAA; B. sp. 9_1_42FAA; B. sp. 3_1_33FAA; and B. dorei 5_1_36/D4 . In contrast, the integrase-encoding sequence was missing in available sequencing data from B. distasonis (ASF519), B. fragilis (ATCC 25285), B. fragilis YCH46, and B. thetaiotaomicron VPI5482 (ATCC 29148). PCR analyses of lysates of B. distasonis and B. thetaiotaomicron VPI5482 confirmed that they were indeed integrase deficient. We therefore used B. vulgatus, which carries the Bac-IYL-encoding integrase gene and was dominant in both murine and human stool samples ( Figures S2C-S2E , S4, and S5), and B. distasonis (ASF519), which does not carry the integrase gene, to ascertain the effects of BacIYL 36-44 on the anti-colitogenic activity of 17.4-CTL in monocolonized IGRPdeficient 17.6-NOD or BALB/c mice. Remarkably, transfer of 17.4-CTL to BALB/c and IGRP-deficient 17.6-NOD mice that were monocolonized with B. vulgatus displayed reductions in disease-activity scores as compared to those seen in mice monocolonized with B. distasonis ( Figure 6A ). Histopathological analyses of colon samples from 17.4-CTL-transferred, monocolonized IGRP-deficient 17.6-NOD mice were consistent with these observations ( Figure 6B ). To ensure that these findings were not due to inherent differences between B. vulgatus and B. distasonis independent of the expression of integrase, we generated an integrase-TG strain of B. thetaiotaomicron, which does not carry an integrase gene, via pNBU2 complementation (Martens et al., 2008) (Figure 6C ). Real-time PCR of DNA from several isolates were consistent with single recombination events, as expected ( Figure 6D ). Wild-type B. thetaiotaomicron and one of the TG isolates ( Figure 6D ) were used for monocolonization experiments.
In agreement with the ability of 17.4-CD8+ CTLs to kill BacIYL 36-44 -pulsed DCs in vitro and in vivo and protect mice against colitis in a perforin-and MHC class I-dependent and DC-specific manner ( Figures 2 and 4 Figure 6G ). In contrast, monocolonization of NOD.scid mice with TG B. thetaiotaomicron had no effect on the ability of CD4+ and CD8+ T cells from specific pathogen-free NOD donors to transfer T1D, as compared to monocolonization with wild-type B. thetaiotaomicron ( Figure 6H ). (H) Penetrance of diabetes in female GF NOD.scid mice monocolonized with wild-type (n = 9) or integrase-expressing B. thetaiotaomicron (n = 11) upon transfer of splenic CD4+ and CD8+ T cells from female pre-diabetic NOD donors. p values were calculated by log-rank test.
DISCUSSION
The commensal microbiota regulates T cell homeostasis, and mammals have co-evolved with a specific consortium of gut bacteria capable of stimulating the maturation of the gut immune system. For example, Th17, induced FoxP3+ Tregs, and Th1 CD4+ T cells, which are important for gut immune homeostasis (Barnes and Powrie, 2009), are absent in GF mice (Geuking et al., 2011; Ivanov et al., 2008; Ivanov et al., 2006) , and certain bacterial species, such as Segmented filamentous bacteria (SFB) or Clostridia spp., are powerful inducers of gut Th1 and Th17 or Treg responses, respectively (Atarashi et al., 2011; Chappert et al., 2013; Gaboriau-Routhiau et al., 2009; Ivanov et al., 2009) . Given the central role that these effector T cells play in autoimmunity, it has long been suspected that alterations in the composition of the gut microbiota, particularly during the neonatal period, might play a role in autoimmunity (Markle et al., 2013) , as documented for SFB in murine arthritis (Wu et al., 2010) and experimental allergic encephalomyelitis (Lee et al., 2011) . The specific mechanisms underlying these putative associations, however, remain poorly understood. Although the gut contains 10 12 bacteria per gram of faecal material, hence exposing the GALT to an enormous and highly diverse antigenic load that likely contains mimics of endogenous self-antigens, the existence and physiological role of such mimicry remain unknown. The data presented here provide direct evidence for a role of molecular mimicry between a self-antigen and a gut microbial antigen in the regulation of colitis, thus paving the way for similar studies in other autoimmune responses. Our work further suggests that spontaneous, induced, or transferred cytotoxic T cells specific for gut microbial epitopes may have therapeutic significance in IBD. IBD results from an exaggerated host response against components of the normal gut microbiota in the face of insults that compromise the integrity of the gut epithelial layer and genetic polymorphisms that promote responsiveness of the gut immune system. The gut microbiota can control gut inflammation by promoting CD4+ Treg cell induction, and in hosts with impaired Treg development, there are heightened colitogenic T cell responses in the lamina propria (Strober, 2013). Our work brings forth an additional, previously unrecognized aspect of homeostatic regulation of the gut that adds to these previous findings: cognate CD8+ T cell responses against microbial antigens can have dramatic protective effects against colitogenic insults. Thus, gut commensals not only induce conventional CD4+ Tregs and inflammatory (effector) CD4+ T-cells, such as in a response to an acute gastrointestinal infection (Hand et al., 2012) , but also function as triggers of CD8+ CTL-based regulation of increased exposure to the microbiota. That a MHC class I-restricted CTL response targeting gut microbial antigen-loaded DCs has anticolitogenic effects is consistent with the hyper-TNFa production by gut DCs in Treg-deficient T-bet/RAG2 double-deficient mice, induced by a pro-colitogenic microbiota (Garrett et al., 2007; Powell et al., 2012) . Although antigen cross-presentation in the intestine is primarily mediated by CD103 + CD11b -DCs, our data suggest that 17.4-CTLs target DCs expressing CD11c and/or CD11b. Additional phenotypic studies will be required to ascertain if a specific subset of DCs is preferentially targeted.
Another intriguing aspect of the current study is that the microbial antigen that elicits the protective CTL responses is expressed by a prevalent strain of the gut bacteria, Bacteroides, previously implicated in CD4+ Treg induction via polysaccharide A (Mazmanian et al., 2008; Round et al., 2011) . Another gut bacterial genus implicated in local FoxP3+ Treg induction is Clostridium (Atarashi et al., 2011) . More recently, it has been shown that a cohort of 17 strains of Clostridia cooperatively produce short-chain fatty acids that elicit TGFb production by epithelial cells, promoting Treg development. This collection of strains enhanced the ability of colonic Tregs to suppress antigen presentation in vitro, suggesting that some of these Tregs might recognize antigens from these bacteria, although direct evidence for this was not provided (Atarashi et al., 2013) . Other studies in gut-tropic TG T cell models also support a role for microbial antigen specificity in host-microbial homeostasis (Cong et al., 2009; Lathrop et al., 2011; Nutsch et al., 2016) . Our study differs from these previous works in that we demonstrate a gut microbial antigen-specific T cell response that has cross-reactivity to a self-antigen.
IGRP 206-214 -specific CD8+ T cells share some similarities with the mucosal-associated invariant T (MAIT) cells, an evolutionarily conserved subset of T cells implicated in gut immune homeostasis (Le Bourhis et al., 2013) . Like MAIT cells, IGRP 206-214 -reactive CD8+ T cells exit the thymus expressing high levels of gut-homing integrins and are abundant in the periphery, amounting to up to 0.7% of CD8+ T cells, as determined by tetramer staining (Amrani et al., 2000; Trudeau et al., 2003) . In addition, although they express a highly heterogenous TCRb repertoire, they consistently express an invariant TCRa rearrangement encoding Va17 and Ja42 elements joined by a germline-encoded CDR3 sequence (Anderson et al., 1999; Han et al., 2005b; Verdaguer et al., 1996) . Similar to MAIT cells, the TCRb chain plays a permissive role in cognate pMHC engagement (Le Bourhis et al., 2013) . These features suggest that by facilitating the formation of the key TCRa rearrangement in the pre-immune repertoire at a high frequency, these cells have been selected by natural evolution. Likewise, when these cells differentiate into memory CD8+ T cells, they express high levels of CD122 and secrete abundant IFNg, but do not proliferate in response to antigen in the absence of IL-2 or IL-15 (Le Bourhis et al., 2013; Tsai et al., 2010) . Finally, these cells are rapidly recruited to the GALT in response to colitogenic insults or monocolonization with integrase-expressing Bacteroides species. These features, coupled to the data shown here, suggest that IGRP 206-214 -reactive T cells exist because they afford the host a survival advantage (i.e., regulation of mucosal immunity and suppression of colitis), diabetes being an unfortunate cross-reactivity (at higher avidity) with a pancreatic b-cell autoantigen.
Although NOD.scid hosts monocolonized with integrase+ or integrase-Bacteroides develop diabetes with similar incidence and kinetics upon splenic T cell transfer, we cannot completely rule out the possibility that molecular mimicry between BacIYL 36-44 and IGRP 206-214 contributes to promoting or suppressing diabetogenesis in wild-type mice. For example, our data indicate that the Bacteroides integrase antigen promotes the recruitment and proliferation of low-avidity (17.6) IGRP 206-214 -reactive CD8+ T cells into the GALT, suggesting that BacIYL 36-44 promotes the generation of memory-like antidiabetogenic CD8+ T cell suppressors, which arise from naive low-avidity T cell precursors in response to chronic antigenic exposure (Amrani et al., 2000; Han et al., 2005a; Tsai et al., 2010) . Our data suggest that the gut milieu provides quantitative (i.e., antigen dose) or qualitative signals (i.e., specific cytokines) that increase the functional avidity of low-avidity IGRP 206-214 -reactive CD8+ T cells (17.6-TCR+) for the integrase mimic. In a sense, these low-avidity autoreactive CD8+ T cells may be analogous to thymic CD4+ Treg cells, which have been recently shown to recognize unidentified gut bacterial antigens (Cebula et al., 2013) .
Collectively, our data provide direct evidence that molecular mimicry between a gut microbial integrase and a self-antigen can contribute to maintenance of normal immune homeostasis. Given the enormity of the gut microbial antigenic universe as compared to its human endogenous counterpart, it would be reasonable to suspect that such cross-reactivities are not rare.
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CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Pere Santamaria (psantama@ucalgary.ca).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice NOD.LtJ, NOD.FVB-Tg(ITGAM-DTR/EGFP)34Lan/JdkJ (NOD.CD11b-DTR), NOD.FVB-Tg(Itgax-DTR/EGFP)57Lan/JdkJ (NOD. CD11c-DTR), NOD.Cg-Il10 < tm1Cgn > /DvsJ (NOD.Il10
-/-), NOD.Cg-Tg(TcrLCMV)327Sdz/DvsJ (LCMV-Gp33-specific TCR-transgenic (P14) NOD), BALB/cJ, C57BL/6J, C57GLKS/J, NZBWF1/J, CBA/2J and B6D2F1/J mice were purchased from the Jackson Laboratory (Bar Harbor, ME). C57BL/6 mice were purchased from Taconic Farms (NY, USA). 17.4-NOD, 17.6-NOD (Han et al., 2005b) , NOD.Prf -/- (Amrani et al., 1999) , NOD. mice. NOD.G6pc2 KI/KI /Rag2 -/-mice were produced by introgressing two copies of the Rag2 mutation from NOD.Rag2 -/-mice into the NOD.G6pc2 KI/KI background. NOD.B6-Itgb7tm1Cgn/2Lt mice were a gift from E.H. Leiter. All other strains described herein were produced by intercrossing and selecting progeny for the desired genotypes by allele-specific PCR.
BALB/c, NOD.scid and IGRP-deficient 17.4-NOD or 17.6-NOD mice were re-derived into germ-free mice by 2-cell embryo transfer into germ-free recipient females at the Clean Mouse Facility of the University of Bern (Switzerland) and bred and maintained in flexible film isolators. Germ-free mice were routinely monitored by culture-dependent and -independent methods and were independently confirmed to be pathogen-free. Germ-free mice were additionally confirmed germ-free prior to specific colonization.
All mice used in this study were sex-and age-matched (around 8-12 weeks old, the gender is indicated below in each experimental procedure). These studies were approved by the institutional Animal Care Committees of the Cumming School of Medicine at the University of Calgary and at the University of Bern.
Human Subjects
Proliferative responsiveness to Bacteroides integrase was measured using PBMCs from five healthy donors (2 males and 3 females, 28-46 (36.6 ± 7.8) years-old), six adult T1D patients (3 females and 3 males, 19-38 (28.8 ± 3.5) years-old) and four CD patients (3 females and 1 male, 28-51 (36.7 ± 5.1) years-old).
pMHC multimer-binding assays were done using PBMC samples from 6 T1D and 6 CD HLA*02:01+ individuals identified among 13 and 24 patients, respectively, via high-resolution HLA typing (T1D: 4 males and 2 females, 23-53 (30.5 ± 4.6) years-old; CD: 4 females and 2 males, 28-71 (43.5 ± 7) years-old).
Metagenome sequencing data was from 8 healthy control subjects (6 females and 2 males, 26-56 (34.1 ± 2.8) year-old, 8 T1D patients (5 females and 3 males, 20-41 (30.2 ± 2.5) year-old), and 8 CD patients (7 females and 1 male, 22-40 (31.2 ± 2.5) year-old).
The human sample collection and studies described herein were approved by the Institutional Review Board of Hospital Clinic de Barcelona (HCB). Informed consent was obtained from all participating individuals. html). The binding threshold was set at 14.56, and peptides with scores greater than the threshold value were predicted to be good H-2K d binders.
H-2K d Stabilization Assay
RMA-SK d cells were cultured overnight at 26 C and seeded at 2x10 5 cells/well in 96-well plates, pulsed with peptides in RPMI-1640, 0.25% BSA for 1 h at 26 C, incubated at 37 C for 3 h, washed, stained with anti-H-2K d -FITC, and analyzed by flow cytometry. Data were calculated by subtracting the mean fluorescence intensity for H-2K d on non-peptide-pulsed cells and the percentage of K d stabilization was calculated using the highest MFI (TUM, 25 mM) as 100% (Anderson et al., 1999) .
Flow Cytometry, Reagents and Antibodies
Prior to staining, single cell suspensions were incubated with purified Rat Anti-Mouse CD16/CD32 (2.4G2) and then stained with FITC, PE, Pacific Blue, Brilliant Violet 785, AP-Cy7, Alexa Fluorâ 647, PE-CF594, PE-Cy7, PE-Cy5, AlexaFluor700, PerCP or AP-conjugated mAbs in FACS staining buffer (0.05% Sodium azide and 1% FBS in PBS) for 30 min at 4 C, washed, fixed in 1% paraformaldehyde (PFA) in PBS and analyzed by FACScan, FACSaria, BD LSRII or Fortessa flow cytometers. The antibodies used included: against mCD3ε (145-2C11, Biolegend), mCD8a (53-6.7, BD Biosciences, Mississauga, or Biolegend), mCD4 (GK1.5, BD, and RM4-5, Biolegend), mCD69 (H1.2F3, Biolegend), mCD44 (IM7, BD Biosciences), mCD122 (5H4, eBioscience, San Diego or TM-b1, BD Biosciences), mCD62L (MEL-14, Biolegend), mCD127 (A7R34, Biolegend), mLPAM1 (DATK32, eBioscience), mCD103 (Integrin aIEL; M290, BD), mIb7(FIB504, BD), mCD49d (integrin a4; 9C10, BD), mCD11c (HL3, BD), mCD11b (M1/70, BD Biosciences), mMHCII (M5/114.15.2, Biolegend), mCD19 (1D3, BD or 6D5, Biolegend), mB220 (RA3-6B2, BD) and mH-2K d (SF1-1.1) (BD-pharmingen), hCD19 (HIB10, eBioscience), hCD4 (OKT4, Biolegend), and hCD8 (RPAT8, Biolegend). Dead cells were excluded by staining with Bioscience Fixable Viability Dye eFluor 506 (eBioscience).
pMHC Tetramers and Avidity Measurements
The peptides mIGRP [206] [207] [208] [209] [210] [211] [212] [213] [214] , NRP-V7, BacIYL 36-44 , hIGRP 207-216 , BacInt 35-44 , TUM, W15944, W1945, W1946 and W1948 (Tai et al., 2016 , and the corresponding tetramers (PE-or AP-labeled) were prepared as described (Amrani et al., 2000) . Briefly, the peptides were incubated with recombinant human b2 m and mouse heavy chains and subjected to gel filtration. The appropriate fractions were pooled and subjected to biotinylation using Biotin ligase (Avidity, Aurora) following the supplier's protocols, followed by ion exchange chromatography using an AKTA FPLC system (GE Healthcare). The final product was verified by both denaturing SDS-PAGE and native PAGE analysis. Tetramers were generated by adding PE-conjugated streptavidin (Rockland Immunologicals, Gilbertsville) at a 4:1 molar ratio. In other experiments, cells from different lymphoid tissues were stained with both Tum/K C, stained with anti-CD8 and anti-B220 mAbs (diluted 1:100 in FACS buffer), washed, fixed in 1% PFA in PBS and analyzed.
Tetramer-binding avidity was measured by incubating 2x10 5 lymphocytes with various concentrations of pMHC tetramer and 0.2 mL of FITC-conjugated anti-CD8 mAb in 20 mL of FACS staining buffer for 45 min at room temperature in the dark. After washing, cells are subject to FACS analyses. Scatchard plots were generated by plotting geometric MFI of tetramer binding population/ [pMHC(nM)] in the y axis and the geometric MFI of tetramer binding in the x axis. The avidity constant was derived from the negative reciprocal of the slope from the linear regression of the curve, as described (Amrani et al., 2000) .
Human PBMC Proliferation Assays
To test the proliferative activity of Bacteroides integrase, we isolated PBMCs from heparinized peripheral blood of five healthy donors (2 males and 3 females, 28-46 (36.6 ± 7.8) years-old), six adult T1D patients (3 females and 3 males, 19-38 (28.8 ± 3.5) yearsold) and four CD patients (3 females and 1 male, 28-51 (36.7 ± 5.1) years-old) by Ficoll (Sigma-Aldrich, Madrid, Spain) gradient centrifugation. Cells were cultured in X-VIVO 15 medium (Bio Whittaker, Lonza, Belgium) supplemented with 2% inactivated AB human serum (Sigma-Aldrich). For T cell proliferation screening, 10 5 PBMCs were cultured with Bacteroides Integrase at 1mg/mL, tetanus toxoid (from Clostridium tetani, #T3194, Sigma-Aldrich) at 1mg/mL, or LPS (from Escherichia coli, #L4391, Sigma-Aldrich) at 1 ng/mL for 7 days. Human recombinant (r-)IL-2 (20 IU/mL; eBioscience, Sand Diego, CA, USA) was added on day 3 of culture. On day 6, tritiated ( 3 H) thymidine (1 mCi/well, Amersham, Cambridge, United Kingdom) was added to the culture in triplicate. The ( 3 H) thymidine incorporation took place during the last 16 h of culture. For MHC-I and MHC-II blocking, anti-HLA-A, B, C (mouse clone DX17, BD Biosciences, San Jose, CA) and anti HLA-DR, DP, DQ (mouse clone TU39, BD Biosciences) were added at 20 mg/mL.
pMHC Pentamer Binding to Human T Cells pMHC multimer-binding assays were done using PBMC samples from 6 T1D and 6 CD HLA*02:01+ individuals identified among 13 and 24 patients, respectively, via high-resolution HLA typing (T1D: 4 males and 2 females, 23-53 (30.5 ± 4.6) years-old; CD: 4 females and 2 males, 28-71 (43.5 ± 7) years-old). PBMCs were isolated using Lymphoprep gradient (Axis Shield). CD8+ T cells were purified by positive selection using magnetic columns following the manufacturer instructions (Miltenyi Biotech). 50x10 6 CD8+ T cells were incubated with 10ml of AP-labeled Pro5âMHC Pentamer (KIYLKTNVYL) and 10ml of PE labeled Pro5âMHC Pentamer (YLKTNLFLFL) for 20 min at RT in PBS containing 0,1% BSA. Pentamer-labeled cells were purified using anti-PE and anti-AP mAb-coated microbeads using magnetic columns. The purified pentamer cell fraction was first labeled with antibodies anti-CD8, anti-CD19, anti-CD4, and LIVE/DEADâ Dye and then resuspended with 50ml of PBS and 50ml of counting beads (Invitrogen) . Total pentamer-specific T cells were calculated as follows: (Pentamer cell counts x Number of beads per mL/Bead counts)*50ml sample volume. Specific pentamer cell numbers per million CD8+ T cells were quantified as follows: Total pentamer cell counts x 10 6 /Total CD8+ T cells. Cells were analyzed on a FACSCantoII (BD) and analysis was performed using FlowJo software.
Recombinant Bacteroides Integrase DNA sequences encoding a truncated Bacteroides integrase (the N-terminal 100aa; full-length integrase expresses poorly in our hands), encoding the wild-type BacIYL 36-44 epitope, were sub-cloned into the pET14b expression vector. BL21(DE3) pLysS strain of E. coli was used as a host for protein expression. After induction with 1mM IPTG for 3h at 37 C, bacteria were spun down and subjected to lysis with BugBuster reagent (EMD Millipore, Billerica). After extensive washes, inclusion bodies were dissolved in 8M urea. Refolding was achieved by stepwise dialysis against 4M urea, 2M urea and PBS. Protein was quantified with the BCA method (Pierce, Rockford). Integrity and purity were examined by SDS-PAGE. Recombinant GST, used as a control antigen, was purified using glutathione agarose beads (EMD Millipore, Billerica) from lysates of IPTG-induced BL21(DE3)pLysS bacteria transformed with pGEX-2TK.
Isolation of Lymphocytes and Myeloid Cells
Briefly, Peyer's patches were dissected and dissociated into single cell suspensions. The remaining intestine was cut open longitudinally and into 5mm pieces. The tissue was washed 3 times with cold dPBS (calcium and magnesium free) with 2mM DTT. IELs were obtained by incubating intestinal tissue with dPBS containing 2mM DTT and 5mM EDTA at 37 C with shaking. The supernatant was passed through a pre-wetted nylon wool to remove debris and most enterocytes. The IELs in the flow-through were collected by centrifugation. LP lymphocytes were isolated from the intestinal tissue after isolation of PPs and IELs. The tissue was subjected to digestion by 100u/mL collagen VIII (Sigma, St. Louis) in RPMI for 1h at 37 C and passed through a 100 mm mesh to collect LP lymphocytes. To measure DC content, cell isolates were stained with FITC-or PE-conjugated mAbs against CD11c and CD11b, respectively, and analyzed by flow cytometry. -/-mice, and the hosts fed with BrdU in the drinking water (0.8mg/mL) for 7 days.
In Vivo BrdU Proliferation Assay
Incorporation of BrdU was analyzed in splenic, bone marrow, pancreatic lymph node (PLN), mesenteric lymph node (MLN), PP, IEL and LP CD8+ T cells using the FITC BrdU Flow Kit (BD PharMingen, Mississauga).
Proliferation and Cytokine Secretion Assays
Purified transgenic 17.4-or 17.6-CD8+ T cells or CD8+ T cells from non-transgenic NOD mice (NTG) were cultured with BM-DCs pulsed with increasing concentrations of TUM, BacIYL [36] [37] [38] [39] [40] [41] [42] [43] [44] , W15944, W15945, W15946 or W15948 peptide in the presence or absence of LPS (1ng/mL). Culture supernatants were evaluated for IFNg content by ELISA (R&D systems) at 72h or pulsed with 3 H-thymidine (at 48h), and harvested (at 72h) to determine the extent of peptide-induced proliferation. Alternatively, cells were harvested after 72h of culture and stained for intracellular IFNg using the Cytofix/Cytoperm kit (BD Bioscience, San Jose, CA). In other experiments, BM-DCs were pulsed with different concentrations of BacInt100aa or OVA protein for 5h, washed and co-cultured with 17.4-CD8+ T cells in the presence or absence of LPS (1ng/mL). Culture supernatants were evaluated at 72h for IFNg content by ELISA. 2% DSS (40kDa; MP Biomedicals, Santa Ana) in the drinking water for one week to compromise the integrity of gut epithelial layer and prime endogenous gut-microbial BacIYL-specific T cells without inducing overt colitis. The mice were then allowed to drink regular water for one week and were subsequently exposed to two or three 3-wk cycles of 3.5% DSS (1 wk) and regular water (2 wk). Body weight was measured daily. In CTL transfer and DT treatment experiments, 17.6-NOD.Tcra .Itgax-DTR mice were exposed to three and two 3-wk cycles of 3.5% DSS (1 wk) and regular water (2 wk), respectively. NOD.Igrp [206] [207] [208] [209] [210] [211] [212] [213] [214] -/-were exposed to three 3wk cycles of 4% of DSS (DSS for 1 wk, followed by regular water for 2 wk). Disease activity scores were assessed at the end of follow-up, as described below.
DSS-Induced Colitis
CTL Generation and Transfer In Vivo P14 (LCMV Gp33)-, 17.4-and 17.6-CTLs were generated by a three day culture of splenic P14-CD8+, 17.4-CD8+ or 17.6-CD8+ T cells with Gp33, IGRP 206-214 /NRP-V7-, BacIYL 36-44 -pulsed APCs for three days in the absence of exogenous cytokines, as described (Wang et al., 2010) . Specifically, splenocytes from donor mice (6-10 wk-old) were cultured in the presence of peptide-pulsed (1 mM, 1 mM and 35 mM, respectively) APCs for 3 days. On day 3, proliferated CTLs were purified using iMAGCD8 beads (BD Bioscience) and cells were transferred into 6-8 wk-old male hosts along with 3.5% or 4% DSS treatment. Mice were transfused with 10-12x10 6 CTLs through the tail vein at the beginning and end of each cycle of DSS or water exposure (3.5 or 4% DSS, as detailed in the figure legends). Experiments were terminated after 3 cycles of DSS exposure, as described above.
In Vitro and In Vivo Cytotoxicity Assays
To measure cytotoxic activity in vitro, we cultured BacIYL 36-44 -peptide pulsed (over a broad range of concentrations) Cr. Specific 51 Cr release was calculated using this formula: percent lysis = 100 3 (test cpm À spontaneous cpm) / (total cpm À spontaneous cpm).
To measure cytotoxicity in vivo, we purified splenic DCs from wild-type NOD mice using anti-CD11c mAb-coated magnetic beads and incubated them with TUM, BacIYL or NRP-V7/IGRP 206-214 peptides (2 mM) for 2 hr. TUM-pulsed DCs were then labeled with PKH26 or CFSE, and BacIYL-and NRP-V7/IGRP 206-214 -pulsed cells were labeled with CFSE. The cells were washed, mixed at 1:1 ratios (TUM versus TUM, ) and transferred intravenously into TCR-TG NOD or NOD.Igrp 206-214 -/-mice (8x10 6 cells/mouse). Spleens were harvested from the hosts 18 hr later and analyzed for presence of the transferred cells. Target-specific DC killing was assessed by calculating the relative percentage of NRP-V7/IGRP 206-214 -versus TUM-or BacIYL-versus TUM-pulsed DC loss relative to the control TUM-versus TUM-pulsed DC values.
DSS-Induced Colitis Activity Scoring
The colon was excised, examined and scored based on the severity of inflammation. The following criteria were used for scoring each mouse from a scale ranging from 0 to a total of 18: length of the colon (if size reduction was < 10% versus non-DSS-treated controls, a score of 1 was given); loss of body weight (scores of 1, 2, 3 and 4 correspond to body weight loses of > 5%, > 10%, > 15% and > 20%, respectively, from original weight); wet anus, bloody anus, fecal blood, fluid field, soft stool, macroscopic ulcer on colon (score of 1 given for each of these, if present, or 0 if absent); hard pellet and empty colon (score of 0 given for each, if present, or a score of 1, if absent); and mouse death or if sacrificed due to severe distress (score of 5).
17.4-CTL Transfer and DNBS-Induced Colitis
BALB/c male mice (> 20 wk-old) were transfused with 17.4-or 17.6-CTL 7 days prior to and on the day of the intra-rectal DNBS administration (4.5 mg in 100 mL of 50% ethanol, under light anesthesia) (Hunter et al., 2010) . Control mice received DNBS but not CTL or neither DNBS nor CTL. Mice were examined for weight loss, fur ruffling, decreased activity, and wet and bloody anus or feces. Mice were scored out of a total of 18 points. Mice which died on days 1 or 2 or had to be killed on day 3 due to severe stress, > 20% weight loss or rectal prolapse were given scores of 18, 10 and 5, respectively. Mice were weighted before killing. The latter were also given additional scores of 1 point each for the following macroscopic signs of colitis: > 10% weight loss; > 10% reduction in colon length versus control; wet anus; bloody anus; fecal blood; fluid fill; soft stool or empty colon; and macroscopic ulcers in colon. The distal part of the colon was fixed in formalin and processed for histopathological analysis by H&E staining as described below. -/-mice were treated with 4ng/g and 25ng/g body weight of DT, respectively, on days 0 and 3 during the first cycle of 3.5% DSS exposure. These mice did not receive DT for the second exposure of 3.5% DSS.
CD4+ T Cell Transfer Model of Colitis
Integrase-Transgenic Bacteroides
The pNBU2-bla-ermGb plasmid (Koropatkin et al., 2008) , kindly provided by JL. Sonnenburg, was used to introduce the Bacteroides Integrase (BacInt) gene at one of two NBU2 sites of the serine-tRNA gene in the B. thetaiotaomicron genome (Wang et al., 2000) . This vector carries an ampicillin (Amp) resistance cassette for selection in E. coli and an erythromycin (Erm)-gentamicin (Gem) resistance cassette for selection in Bacteroides species. The BacInt gene was excised from plasmid pcDNA4/TO/myc-His-BacInt using EcoRI and BamHI (Promega) and then cloned into pNBU2-bla-ermGb. In order to express the BacInt under the Sigma70 promoter (BT1311), the promoter BT1311 was PCR amplified from B. thetaiotaomicron genomic DNA using primers fwd-XbaI 5 0 -AAAATCTAGAT GATCTGGAAGAAGCAATGAAAGC-3 0 and rev-BamHI 5 0 -AAAAGGATCCTTAAAAACAGATTTGGAGTGCAA A-3 0 . The BT1311 promoter was then cloned into the pGEMâ-T Easy Vector (Promega) and excised using XbaI and BamHI (Promega) in order to clone in upstream of the BacInt construct in pNBU2-bla-ermGb. The complete construct was introduced into anaerobic B. thetaiotaomicron (Integrase-negative; ATCC29148) by conjugation using the E. coli S17.1l pir strain (Koropatkin et al., 2008 ). E. coli S17.1l pir was transformed with the pNBU2-bla-ermGb-BT1311-BacInt construct and selected on LB agar+Amp (100 mg/mL, Sigma) plates for 12-14 hours. Amp-resistant colonies of E. coli S17.1l were picked and grown overnight aerobically in LB broth at 37 C. At the same time, B. thetaiotaomicron was grown anaerobically overnight at 37 C in Thioglycollate broth (CM0391, Oxoid). The following day, both strains of bacteria were sub-cultured for 3-4 hours at 37 C at a 1:1 density ratio, which allows for more efficient conjugation. Conjugation was performed by plating the 1:1 mixture on BHI (Brain Hearth Infusion, CM1135, Oxoid)+10% sheep blood agar aerobically at 37 C for 16-24 hours. The next day, bacteria were scraped from the plate, plated on BHI-blood agar containing Gem (200 mg/mL, Sigma) and Erm (25 mg/mL, Sigma) to select for B. thetaiotaomicron colonies carrying the pNBU2-bla-ermGb-BT1311-BacInt construct, integrated in their genome. The genetically modified B. thetaiotaomicron were incubated anaerobically at 37 C for 4 days and the individual recombinant colonies were isolated and screened by PCR for the presence of the BT1311prom-BacInt construct using primers fwd-XbaI 5 0 -AAAATCTAGATGATCTGGAAGAAGCAA TGAAAG C-3 0 and Int-rev 5 0 -GCAGCCAATGCACAAATGCTG-3 0 .
16S rDNA Gene Sequence Analysis
Fresh faecal pellets from mice were collected into sterile 1.5mL microcentrifuge tubes at the same time and immediately placed on dry ice. Faecal genomic DNA (gDNA) was prepared using the QIAamp Fast DNA Stool Mini Kit (QIAGEN) according to the manufacturer's instructions, with additional homogenization using glass beads at 30Hz for 3min and Lysozyme (20 mg/mL, Sigma-Aldrich) treatment to obtain good quality and quantity DNA from both Gram-negative and Gram-positive bacteria contained in the fecal samples. Faecal DNA was ethanol-precipitated on to kit column membranes and eluted in sterile water. The concentration and purity of the isolated DNA were evaluated using NanoDropâ (Thermo Scientific). The V5/V6 region of 16S rDNA genes was amplified as previously described (Li et al., 2015; Sundquist et al., 2007) from 200 ng of faecal DNA using a range of oligonucleotide primers specific for the V5 and V6 domains of bacterial rDNA. PCR products were then purified after 1% agarose gel electrophoresis using a Gel Extraction Kit following the manufacturer's instructions (QIAGEN). Purified amplicon concentration and purity were evaluated by quBit 3.0 Fluorometer (Thermo Fisher) prior to proceeding to the library preparation. All samples were prepared for sequencing using the Ion OneTouch2 Instruments, with the Ion PGM Template Hi-Q OT2 400 Kit (for up to 400 base-read libraries) (Thermo Fisher) and the Ion Personal Genome Machine (PGM) System with the Ion PGM Sequencing Hi-Q Kit and the Ion 316.v2 Chips (Thermo Fisher). All these instruments are housed in the Next Generation Sequencing platform of the University of Bern.
Analysis of the sequencing data was performed using the QIIME pipeline version 1.9.1 (Caporaso et al., 2010) . Taxonomy assignment was performed using the latest GreenGenes database (http://greengenes.secondgenome.com). Samples with over 20000 reads were accepted for analysis.
Shotgun Metagenomic Sequencing and Analysis
To create a reference database containing the gene sequences of each IGRP 206-214 homolog, we first retrieved GenBank protein records for the 48 protein accession numbers listed in Table S1 . Thirty-eight of these records contained linkages to corresponding genome accession numbers and open reading frame start/stop positions (Table S2 ). However, ten of the protein sequence records were deprecated and no longer contained links to corresponding nucleotide records. To identify an appropriate gene sequence for these proteins, we aligned the deprecated protein sequences to NCBI's non-redundant protein database using BLASTP. For each query we chose an active protein record that was 100% identical to and from the same species as the original protein record, and added its corresponding gene sequence to our database. Redundancies in the reference database were removed by clustering with CD-HIT (Li and Godzik, 2006) using the cd-hit-est command with the following parameters: -s 0.9 -aL 0.9 -n 9. The clustering grouped sequences that were at least 95% similar with length differences less than 10%. The final reference database, containing one representative per cluster, contained 32 IGRP 206-214 mimic encoding gene sequences (Table S2) .
Our search for IGRP 206-214 mimic encoding microbes in the gut microbiome encompassed two existing cohort studies with publically available shotgun metagenomic datasets. The first readset was derived from the baseline samples of children (< 22 years) with Pediatric CD enrolled in a study to examine the role the microbiome in reducing inflammation upon initiation of a defined formula diet (Lewis et al., 2015) . Paired end reads generated for the Lewis study with an Illumina Hi-Seq instrument (100 bp) were downloaded from NCBI SRA (SRP057027). The study's 26 healthy controls (Wu et al., 2011) were paired with a random selection of 26 of the study's 86 sequenced baseline samples from pediatric CD patients. The second readset came from a longitudinal study of microbiome development in infants with HLA risk alleles predisposing them for T1D (Kostic et al., 2015) . We analyzed all 124 samples selected for shotgun sequencing in the study, including those from 7 infants who seroconverted to serum autoantibody positivity, 4 who seroconverted and then developed T1D, and 22 who remained healthy during the study period. Paired end reads from an Illumina Hi-Seq instrument (101 bp) were obtained from the Broad Institute (https://pubs.broadinstitute.org/ diabimmune/). FastQC (https://www.bioinformatics.babraham.ac.uk/projects/fastqc/) inspection of both readsets detected residual 3 0 adaptor contamination and low-complexity reads. We thus carried out a series of quality filtering steps that included 3 0 adaptor trimming and length filtering with cutadapt (-a < adaptor seq > -A < adaptor seq > -m 60) (Martin, 2011), deduplication and low complexity filtering with PRINSEQ (-lc_method dust -lc_threshold 7 -derep 1 [Schmieder and Edwards, 2011]), and human masking with BMtagger (software obtained from ftp://ftp.ncbi.nlm.nih.gov/pub/agarwala/bmtagger and used with a human hg19 reference set inclusive of mitochondrial DNA from (Naccache et al., 2014) ). Remaining paired reads were used in subsequent analyses.
To identify IGRP 206-214 mimic encoding genes in each metagenome, we aligned each readset to the 32-sequence reference database described above using BBMap (https://sourceforge.net/projects/bbmap/). Pairs of reads were allowed to align to multiple sequences with a minimum identity threshold of 90%, as dictated with the following parameters: minid = 0.9 killbadpairs = t pairedonly = t ambiguous = all. Coverage data output by BBMap (covstats) was used to define the presence of an IGRP 206-214 mimic encoding genes (presence of the gene was denoted by average positional coverage of R 1X). The taxonomic composition of each metagenome was profiled using MetaPhlAn v2.0 (Segata et al., 2012) . Genus and species relative abundances provided by MetaPhlAn included data from multiple Kingdoms (Eukaryota, Bacteria, Archaea, and Viruses); these were adjusted to reflect Kingdom-specific relative abundances (i.e., the relative abundance of Bacteroides spp. in relation to detected Bacteria). This and all other data manipulations/statistical analyses were performed using Stata 14 (StataCorp LLC).
New metagenomic readsets were generated for this study's mouse and human cohorts (24 and 23 samples, respectively) in two high output runs on an Illumina NextSeq 500 instrument. Mouse and human stool DNA samples were purified from fresh stool samples using the QIAamp Fast DNA Stool Mini (QIAGEN) or PSPâ Spin Stool DNA Plus (Stratec Molecular GmbH, Berlin, Germany) kits, respectively, and frozen at À80 C. Shotgun metagenomic sequencing was performed at the Centre for Health Genomics and Informatics at the University of Calgary. Briefly, gDNA samples were treated with RNase to remove contaminating RNA. gDNA was then fragmented using Covaris shearing. Libraries were prepared using NEBNext Ultra II kits (NEB) and Shotgun metagenomic sequencing was performed on a NextSeq500 using a 300-cycle high output mode. We generated metagenome sequencing data from 8 controls (6 females and 2 males, 26-56 (34.1 ± 2.8) year-old, 8 T1D patients (5 females and 3 males, 20-41 (30.2 ± 2.5) year-old), and 8 CD patients (7 females and 1 male, 22-40 (31.2 ± 2.5) year-old). These 150 nt paired end runs yielded 274 and 320 GB of data corresponding to 4.24e8 and 5.34e8 read pairs, respectively. NextSeq reads were subjected to comprehensive quality control (3 0 and 5 0 end quality trimming, deduplication, and low complexity filtering) using the following PRINSEQ options: -lc_method dust -lc_threshold 7 -ns_max_p 5 -derep 1 -min_len 60 -trim_qual_left 20 -trim_qual_right 20 -trim_qual_window 10 -trim_qual_step 2 -noniupac. Mouse sequences were masked with BMtagger using the repeat masked NOD mouse reference sequence (ftp://ftp-mouse.sanger.ac.uk/current_denovo/NOD_ShiLtJ.chromosomes.unplaced.gt2k.fa.masked.gz). Human masking, alignment to our database of IGRP 206-214 mimic encoding gene sequences, and MetaPhlAn v2.0 analyses were conducted as described above. 
Monocolonized Mice and DNBS-Colitis
Germ-free mice were weaned into different isolators and then inoculated via intra-gastric gavage with B. distasonis (Sarma-Rupavtarm et al., 2004) , B. vulgatus (ATCC), B. thetaiotaomicron (ATCC) or integrase-expressing B. thetaiotaomicron (this paper) grown anaerobically at 37 C overnight in Brain Hearth Infusion (BHI, CM1135, Oxoid) or Thioglycollate broth (CM0391, Oxoid) with the addition of hemin (1 mg/mL, Sigma) and menadione (0.5 mg/mL, Sigma). Male and female animals were allowed to colonize for 3-6.5 wk. Faecal samples were collected to confirm monocolonization (no other bacterial species and presence of the gavaged integrase-or integrase+ bacteria). The effects of monocolonization of the peripheral and GALT 17.6-CD8+ T cell content were also analyzed at this time. In other experiments, monocolonized male 17.6-NOD.Tcra -/-.Igrp [206] [207] [208] [209] [210] [211] [212] [213] [214] -/-or BALB/c mice were transfused with 17.4-CD8+ CTL or left alone and then exposed to DNBS (1.5 mg/mouse) in ethanol or to ethanol only as described above. Mice were scored out of a total of 18 points, as described above.
Monocolonized NOD.scid Mice and T1D Transfer Germ-free NOD.scid mice (5-9 wk-old) were monocolonized with either Integrase+ or Integrase-B. thetaiotaomicron for 5 days. Monocolonized age-matched male and female hosts were transfused with 2x10 7 splenic T cells isolated from gender-matched pre-diabetic SPF NOD donors (kindly provided by F. Grassi) using mouse CD4 (L3T4) and CD8a (Ly-2) Micro-Beads (Miltenyi-Biotec). Hosts were monitored weekly for hyperglycemia for at least 100 days, using a glucometer (Xpress, Nova Biomedicals, UK) and Glutest strips (StatStrip Xpress, Nova Biomedical, UK).
Colon Histopathology
The entire colon was incised longitudinally to produce a flat sheet of colon tissue. The colon was then rolled from the distal to proximal end, transected with a 27G needle, fixed in 10% neutral formalin at room temperature for at least 24 h, paraffin-embedded, sectioned (6 mM), mounted on slides, stained with H&E. Histological damage was scored using a 12-point scale as described (Hunter et al., 2010) , using the following criteria: loss of architecture, 0-3; cellular infiltration, 0-3; ulcers, 0-1; goblet cell depletion, 0-1; edema, 0-1; muscle thickening, 0-2; and crypt abscesses, 0-1.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis was performed in GraphPad Prism statistical software (version 6). p values were calculated using ANOVA, t test, Mann-Whitney U-test, Spearman's correlation test or c2 test, as indicated. p value < 0.05 was considered statistically significant.
DATA AND SOFTWARE AVAILABILITY
The 16S rDNA and Metagenome sequencing data were deposited in the NCBI Bioproject database (ID number: PRJNA397664; https://www.ncbi.nlm.nih.gov/bioproject/397664). 
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